You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歐康維視生物-B(01477.HK)先舊後新配售2800萬股 淨籌7.82億港元
格隆匯 01-22 22:16

格隆匯 1 月 22日丨歐康維視生物-B(01477.HK)公佈,有關擬先舊後新配售2800萬股事項,配售事項及認購事項已分別於2021年1月15日及2021年1月22日根據該協議的條款及條件完成。於2021年1月15日,配售代理已根據該協議按每股股份28.35港元的配售價,向不少於六名承配人成功配售合共2800萬股配售股份。

認購事項已於2021年1月22日完成,並由賣方按每股認購股份28.35港元的認購價認購合共2800萬股認購股份(相等於根據配售事項成功配售的配售股份數目)。認購股份相當於經認購事項擴大的公司已發行股本約4.52%。

認購事項所得款項總額約為7.938億港元。認購事項所得款項淨額約為7.817億港元。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account